期刊文献+

血清学指标联合筛查对胃癌诊断的临床意义 被引量:4

Clinical Significance of the Combined Detection of Serologic Parameters in the Diagnosis of Gastric Cancer
下载PDF
导出
摘要 目的用统计学和生物信息学找到胃癌早期诊断的生物标志,建立诊断模型。方法回顾性分析解放军总医院2009年至2010年消化科的住院患者179例,根据胃镜检查结果分为胃癌组(139例)和不典型增生组(40例)。用统计学的多参数法分析胃癌和不典型增生患者的血清学参数。用SPSS18.0统计学软件分析两组血清肿瘤标志物、细胞因子以及常规生化指标的差异,建立分类模型。结果在所有的血清学指标中,两组有20项有差异(P<0.05),其中12项具有显著差异(P<0.01)。单一指标的诊断准确率均较低,IL-6和CEA的诊断水平最高,曲线下面积(AUC)分别为0.824和0.721。Logistic回归分析显示,CEA、CA72-4、IL-6、IMA、SOD和ApoA1在胃癌的鉴别诊断中有重要的统计学意义,分类预测准确度达85.3%。结论用统计学软件对大量数据进行挖掘,为胃癌的早期诊断提供了有前景的研究方向。CEA、CA72-4、IL-6、IMA、SOD和ApoA1在胃癌和不典型增生的鉴别诊断中有着重要的意义。 Objective To set up a diagnostic model of gastric cancer by using biomarkers for differential diagnosis of early gastric cancer through statistics and bioinformatics technologies. Methods We used retrospective cohort study to screening 179 cases of gastric associated diseases. 139 cases of gastric cancer and 40 cases of atypical hyperplasia were separated by the diagnosis of gastroscopy. The serological parameter differences were analyzed by statistical multi-parameter analysis between gastric cancer and atypical hyperplasia. SPSS18.0 software was adopted for analysis of tumor markers cytokines and biochemical indicators in two groups to set up a diagnostic model. Results There were significant difference in 20 parameters between gastric cancer and atypical hyperplasia (P 〈 0. 05 ). The diagnosis accuracy of single marker was low. The diagnosis horizontal of the IL-6 and CEA were highest. The AUC was 0. 824 and 0. 721, respectively. The results of logistic regression analysis showed CEA, CA72-4, IL-6, IMA, SOD and ApoA1 had significant differences in the differential diagnosis for gastric cancer, and the prediction accuracy of two groups was 85.3 %. Conclusion This study provides a promising strategy for differential diagnosis of gastric cancer with statistics software. The parameters of CEA, CA72-4, IMA, SOD and ApoA1 may have important roles in the predicted classification of gastric cancer and atypical hyperplasia with linear pattern.
作者 周扬 田亚平
出处 《标记免疫分析与临床》 CAS 2014年第5期520-524,共5页 Labeled Immunoassays and Clinical Medicine
关键词 胃癌 不典型增生 血清学参数 多参数分析 Gastric cancer Atypical hyperplasia Serologic parameter Multi- parameter analysis
  • 相关文献

参考文献15

  • 1Parkin D M. International variation. Oncogene, 2004,23 (38):6329-6340.
  • 2Wolff J J,Laremore T N,Leach li FE et al. Electron capturedissociation,electron detachment dissociation and infraredmultiphoton dissociation of sucrose octasulfate. Eur J MassSpectrom (Chichester,Eng) ,2009,15(2) :275-281.
  • 3Manrelli D, Roviello F, De Stefano A,et al. Prognostic significanceof CEA,CA19-9 and CA72-4 preoperative serum levels in gastriccarcinoma. Oncology, 1999,57(1) : 55-62.
  • 4吴道宏,吴本俨,王卫华.血清CA19-9和CA724对老年不同器官恶性肿瘤临床应用价值分析[J].中华老年多器官疾病杂志,2003,2(1):56-56. 被引量:9
  • 5Strieter R M, Chensue S W, Basha M A, et al. Human alveolarmacrophage gene expression of interleukin-8 by tumor necrosisfactor-alpha, lipopolysaccharide, and interleukin-1 beta. Am JRespir Cell Mol Biol, 1990,2 (4) :321-326.
  • 6Ito R,Kitadai Y,Kyo E,et al. Interleukin -1 acts as an autocrinegrowth stimulator for human gastric carcinoma cell. Cancer Res,1993,53(17):4102-4106.
  • 7Niwa T, Miyazaki T, Sato M, et al. Interleukin 8 andbiocompatibility of dialysis membranes. Am J Nephrol, 1995 , 15(3):181-185.
  • 8Bar-Or D, Curtis G, Rao N, et al. C Characterization of theCo (2 + ) and Ni ( 2 + ) binding amino- acid residues of theN-terminus of human albumin. An insight into the mechanism of anew assay for myocardial ischemia . Eur J Biochem,2001,268 (1):42-47.
  • 9孙金芳.缺血修饰白蛋白的检测及临床应用[J].医学综述,2008,14(17):2640-2642. 被引量:10
  • 10Guo E, Chen L, Xie Q, et al. Serum HDL*C as a PotentialBiomarker for Nodal Stages in Gastric Cancer. Ann Surg Oncol,2007,14(9) : 2528-2534.

二级参考文献19

  • 1李志艳,徐国宾,夏铁安.2004年美国临床生化科学院心肌生化标志物应用指南(草案)介绍[J].诊断学理论与实践,2004,3(5):388-392. 被引量:10
  • 2Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia preliminary report[J]. J Emerg Med,2000,19(4) :311-315.
  • 3Bhagavan NV, Lai EM, Rios PA. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction[ J]. Clin Chem,2003,49 (4) :581-585.
  • 4Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients:a multicenter study[ J]. Clin Chem,2001,47 (3) : 464 -470.
  • 5Sinha MK, Roy D, Gaze DC, et al. Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes [ J ]. Emerg Med J, 2004,21 ( 1 ) :29-34.
  • 6Gidenne S, Ceppa F, Fontan E, et al. Analytical performance of the Albumin Cobalt Binding (ACB) test on the Cobas MIRA plus analyzer [ J]. Clin Chem Lab Med,2004,42 (4) :455-461.
  • 7Collinson PO, Moreno PR. Validation of a novel blood test for ischaemia induced during percutaneous coronary intervention [ J ]. Clin Chem,2003,49(6 Suppl) :A38.
  • 8Sirtha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention [ J ]. Circulation, 2003,107 ( 19 ) : 2403 -2405.
  • 9Chan MY, Pronovost PJ. Clinical utility of biomarkers in myocardial injury[ J]. Curr Opin Anaesthesiol,2004,17 (1) :49-55.
  • 10Anwaruddin S, Januzzi JL Jr, Baggish Al, et al. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting[J]. Am J Clin Pathol,2005,124 (5) :817-820.

共引文献17

同被引文献42

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部